Immune system and bone metabolism: Does thymectomy influence postmenopausal bone loss in humans?

Bone

Volumn 39, Issue 3, 2006, Pages 658-665

  D'Amelio, Patrizia ^a   Grimaldi, Anastasia ^a   Bernabei, Paola ^a   Pescarmona, Gian Piero ^a   Isaia, Giancarlo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

IL 7; Postmenopausal osteoporosis; RANKL; Thymectomy; TNF

Indexed keywords

INTERLEUKIN 7; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; B LYMPHOCYTE; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MYASTHENIA GRAVIS; OSTEOLYSIS; POSTMENOPAUSE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMECTOMY; THYMUS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BONE DENSITY; CARRIER PROTEINS; CYTOKINES; FEMALE; HUMANS; IMMUNE SYSTEM; LYMPHOCYTE COUNT; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; THYMECTOMY;

EID: 33746642148     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.03.009     Document Type: Article

References (29)

1. Rosen C.J., Usiskin K., Owens M., Barlascini C.O., Belsky M., and Adler R.A. T lymphocyte surface antigen markers in osteoporosis. J. Bone Miner. Res. 5 8 (1990) 851-855
2. Imai Y., Tsunenari T., Fukase M., and Fujita T. Quantitative bone histomorphometry and circulating T lymphocyte subsets in postmenopausal osteoporosis. J. Bone Miner. Res. 5 4 (1990) 393-399
3. Hustmyer F.G., Walker E., Yu X.P., Girasole G., Sakagami Y., Peacock M., et al. Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis. J. Bone Miner. Res. 8 1 (1993) 51-59
4. Duke-Cohan J.S., Weinberg H., Sharon R., and Naor D. Immunological function in osteoporosis. Clin. Immunol. Immunopathol. 35 1 (1985) 125-129
5. Abrahamsen B., Bendtzen K., and Beck-Nielsen H. Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra. Bone 20 3 (1997) 251-258
6. Pietschmann P., Grisar J., Thien R., Willheim M., Kerschan-Schindl K., Preisinger E., et al. Immune phenotype and intracellular cytokine production of peripheral blood mononuclear cells from postmenopausal patients with osteoporotic fractures. Exp. Gerontol. 36 10 (2001) 1749-1759
7. Horwood N.J., Kartsogiannis V., Quinn J.M., Romas E., Martin T.J., and Gillespie M.T. Activated T lymphocytes support osteoclast formation in vitro. Biochem. Biophys. Res. Commun. 265 1 (1999) 144-150
8. Cenci S., Weitzmann M.N., Roggia C., Namba N., Novack D., Woodring J., et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J. Clin. Invest. 106 10 (2000) 1229-1237
9. Cenci S., Toraldo G., Weitzmann M.N., Roggia C., Gao Y., Qian W.P., et al. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc. Natl. Acad. Sci. U. S. A. 100 18 (2003) 10405-10410
10. Roggia C., Gao Y., Cenci S., Weitzmann M.N., Toraldo G., Isaia G., et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc. Natl. Acad. Sci. U. S. A. 98 24 (2001) 13960-13965
11. Toraldo G., Roggia C., Qian W.P., Pacifici R., and Weitzmann M.N. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc. Natl. Acad. Sci. U. S. A. 100 1 (2003) 125-130
12. Weitzmann M.N., Cenci S., Rifas L., Brown C., and Pacifici R. Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood 96 5 (2000) 1873-1878
13. Miyaura C., Onoe Y., Inada M., Maki K., Ikuta K., Ito M., et al. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc. Natl. Acad. Sci. U. S. A. 94 17 (1997) 9360-9365
14. Hofmeister R., Khaled A.R., Benbernou N., Rajnavolgyi E., Muegge K., and Durum S.K. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev. 10 1 (1999) 41-60
15. Komschlies K.L., Back T.T., Gregorio T.A., Gruys M.E., Damia G., Wiltrout R.H., et al. Effects of rhIL-7 on leukocyte subsets in mice: implications for antitumor activity. Immunol. Ser. 61 (1994) 95-104
16. Fry T.J., and Mackall C.L. Interleukin-7: from bench to clinic. Blood 99 11 (2002) 3892-3904
17. Grone A. Keratinocytes and cytokines. Vet. Immunol. Immunopathol. 88 1-2 (2002) 1-12
18. Giuliani N., Colla S., Sala R., Moroni M., Lazzaretti M., La Monica S., et al. Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease. Blood 100 13 (2002) 4615-4621
19. Lee S.K., Kalinowski J.F., Jastrzebski S.L., Puddington L., and Lorenzo J.A. Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis. Endocrinology 144 8 (2003) 3524-3531
20. Heng T.S., Goldberg G.L., Gray D.H., Sutherland J.S., Chidgey A.P., and Boyd R.L. Effects of castration on thymocyte development in two different models of thymic involution. J. Immunol. 175 5 (2005) 2982-2993
21. Sutherland J.S., Goldberg G.L., Hammett M.V., Uldrich A.P., Berzins S.P., Heng T.S., et al. Activation of thymic regeneration in mice and humans following androgen blockade. J. Immunol. 175 4 (2005) 2741-2753
22. Gerli R., Paganelli R., Cossarizza A., Muscat C., Piccolo G., Barbieri D., et al. Long-term immunologic effects of thymectomy in patients with Myasthenia gravis. J. Allergy Clin. Immunol. 103 5 Pt. 1 (1999) 865-872
23. Shimizu H., Ichikawa Y., Yoshida M., Takahashi K., and Arimori S. Lymphocyte subsets of the peripheral blood in Myasthenia gravis determined by two-color flow cytometry. Autoimmunity 6 3 (1990) 173-182
24. Sempowski G., Thomasch J., Gooding M., Hale L., Edwards L., Ciafaloni E., et al. Effect of thymectomy on human peripheral blood T cell pools in Myasthenia gravis. J. Immunol. 166 4 (2001) 2808-2817
25. Pacifici R., Brown C., Puscheck E., Friedrich E., Slatopolsky E., Maggio D., et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. U. S. A. 88 12 (1991) 5134-5138
26. Sass D.A., Liss T., Bowman A.R., Rucinski B., Popoff S.N., Pan Z., et al. The role of the T-lymphocyte in estrogen deficiency osteopenia. J. Bone Miner. Res. 12 3 (1997) 479-486
27. D'Amelio P., Grimaldi A., Pescarmona G.P., Tamone C., Roato I., and Isaia G. Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis. FASEB J. 19 3 (2005) 410-412
28. Kotake S., Udagawa N., Hakoda M., Mogi M., Yano K., Tsuda E., et al. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum. 44 5 (2001) 1003-1012
29. Kudo O., Fujikawa Y., Itonaga I., Sabokbar A., Torisu T., and Athanasou N.A. Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation. J. Pathol. 198 2 (2002) 220-227